Baidu
map
HISTOPATHOLOGY 润色咨询

HISTOPATHOLOGY

出版年份:1977 年文章数:2029 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:6.9% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2125490, encodeId=26b621254901c, content=投稿以后一直Under Review,中间修改了一次格式,5天了这个状态也不知道送审没有?问助理编辑说已经送到编辑手里了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Wed Apr 12 19:24:43 CST 2023, time=2023-04-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1203553, encodeId=066812035532c, content=请问这个杂志还收几个CASE的这种文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/73A8DFA52E5E794376E9A901459F3815/100, createdBy=b0972241547, createdName=Mascara, createdTime=Thu Mar 17 19:44:04 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110666, encodeId=9f0f2110666e4, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;预后;生信<br>经验分享:精心准备了1个月,审了不到一周直接给拒了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74bd1969714, createdName=1e159c33m59(暂无匿称), createdTime=Wed Jan 18 00:13:30 CST 2023, time=2023-01-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1084305, encodeId=7075108430535, content=12-26投出一篇文章,编号870,按每年文章数200计算,接受率大概在四分之一,期待结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e05538742, createdName=李明胤1234, createdTime=Sun Dec 26 02:54:33 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091142, encodeId=23d1109114236, content=选刊时需要从高到低设置期刊梯度吗?一般设置几个梯度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091141, encodeId=ea4b109114125, content=如何评估自身文章的IF,或者说如何更好地定位自己的文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999047, encodeId=2a4599904e61, content=7月号投稿成功,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64245547622, createdName=ms7000000000217945, createdTime=Tue Jul 13 10:29:00 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969886, encodeId=942e9698867d, content=版面费好贵!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3cEsefDtr3SksqpiatQphbNU2zjlFgLM5KAxKCPSC5p6Zmf5dTnDwmicF8Q2meU3hoXs3t5B6KD8Q/132, createdBy=b5265362396, createdName=医学森4783, createdTime=Mon May 31 16:21:09 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914916, encodeId=40b191491635, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;病理;基因<br>经验分享:2020.12.26投稿---2020.12.30under review---2021.1.4awaiting AE assignment----2021.1.6Awaiting Referee assignment-----2021.1.7Awaiting Referee Scores----2021.1.9awaiting chief editor decision<br>祈祷中,杂志速度极快,以往经验3周肯定一审结束,语言要求高。等待最终结果中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226694480, createdName=mariner2008, createdTime=Sat Jan 09 15:51:03 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883268, encodeId=204c88326848, content=9.7Awaiting AE Recommendation,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a133003278, createdName=502198970, createdTime=Mon Sep 07 09:49:45 CST 2020, time=2020-09-07, status=1, ipAttribution=)]
    2023-04-12 庸医小郝 来自湖北省

    投稿以后一直Under Review,中间修改了一次格式,5天了这个状态也不知道送审没有?问助理编辑说已经送到编辑手里了。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2125490, encodeId=26b621254901c, content=投稿以后一直Under Review,中间修改了一次格式,5天了这个状态也不知道送审没有?问助理编辑说已经送到编辑手里了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Wed Apr 12 19:24:43 CST 2023, time=2023-04-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1203553, encodeId=066812035532c, content=请问这个杂志还收几个CASE的这种文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/73A8DFA52E5E794376E9A901459F3815/100, createdBy=b0972241547, createdName=Mascara, createdTime=Thu Mar 17 19:44:04 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110666, encodeId=9f0f2110666e4, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;预后;生信<br>经验分享:精心准备了1个月,审了不到一周直接给拒了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74bd1969714, createdName=1e159c33m59(暂无匿称), createdTime=Wed Jan 18 00:13:30 CST 2023, time=2023-01-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1084305, encodeId=7075108430535, content=12-26投出一篇文章,编号870,按每年文章数200计算,接受率大概在四分之一,期待结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e05538742, createdName=李明胤1234, createdTime=Sun Dec 26 02:54:33 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091142, encodeId=23d1109114236, content=选刊时需要从高到低设置期刊梯度吗?一般设置几个梯度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091141, encodeId=ea4b109114125, content=如何评估自身文章的IF,或者说如何更好地定位自己的文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999047, encodeId=2a4599904e61, content=7月号投稿成功,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64245547622, createdName=ms7000000000217945, createdTime=Tue Jul 13 10:29:00 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969886, encodeId=942e9698867d, content=版面费好贵!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3cEsefDtr3SksqpiatQphbNU2zjlFgLM5KAxKCPSC5p6Zmf5dTnDwmicF8Q2meU3hoXs3t5B6KD8Q/132, createdBy=b5265362396, createdName=医学森4783, createdTime=Mon May 31 16:21:09 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914916, encodeId=40b191491635, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;病理;基因<br>经验分享:2020.12.26投稿---2020.12.30under review---2021.1.4awaiting AE assignment----2021.1.6Awaiting Referee assignment-----2021.1.7Awaiting Referee Scores----2021.1.9awaiting chief editor decision<br>祈祷中,杂志速度极快,以往经验3周肯定一审结束,语言要求高。等待最终结果中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226694480, createdName=mariner2008, createdTime=Sat Jan 09 15:51:03 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883268, encodeId=204c88326848, content=9.7Awaiting AE Recommendation,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a133003278, createdName=502198970, createdTime=Mon Sep 07 09:49:45 CST 2020, time=2020-09-07, status=1, ipAttribution=)]
    2022-03-17 Mascara

    请问这个杂志还收几个CASE的这种文章吗

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2125490, encodeId=26b621254901c, content=投稿以后一直Under Review,中间修改了一次格式,5天了这个状态也不知道送审没有?问助理编辑说已经送到编辑手里了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Wed Apr 12 19:24:43 CST 2023, time=2023-04-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1203553, encodeId=066812035532c, content=请问这个杂志还收几个CASE的这种文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/73A8DFA52E5E794376E9A901459F3815/100, createdBy=b0972241547, createdName=Mascara, createdTime=Thu Mar 17 19:44:04 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110666, encodeId=9f0f2110666e4, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;预后;生信<br>经验分享:精心准备了1个月,审了不到一周直接给拒了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74bd1969714, createdName=1e159c33m59(暂无匿称), createdTime=Wed Jan 18 00:13:30 CST 2023, time=2023-01-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1084305, encodeId=7075108430535, content=12-26投出一篇文章,编号870,按每年文章数200计算,接受率大概在四分之一,期待结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e05538742, createdName=李明胤1234, createdTime=Sun Dec 26 02:54:33 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091142, encodeId=23d1109114236, content=选刊时需要从高到低设置期刊梯度吗?一般设置几个梯度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091141, encodeId=ea4b109114125, content=如何评估自身文章的IF,或者说如何更好地定位自己的文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999047, encodeId=2a4599904e61, content=7月号投稿成功,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64245547622, createdName=ms7000000000217945, createdTime=Tue Jul 13 10:29:00 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969886, encodeId=942e9698867d, content=版面费好贵!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3cEsefDtr3SksqpiatQphbNU2zjlFgLM5KAxKCPSC5p6Zmf5dTnDwmicF8Q2meU3hoXs3t5B6KD8Q/132, createdBy=b5265362396, createdName=医学森4783, createdTime=Mon May 31 16:21:09 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914916, encodeId=40b191491635, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;病理;基因<br>经验分享:2020.12.26投稿---2020.12.30under review---2021.1.4awaiting AE assignment----2021.1.6Awaiting Referee assignment-----2021.1.7Awaiting Referee Scores----2021.1.9awaiting chief editor decision<br>祈祷中,杂志速度极快,以往经验3周肯定一审结束,语言要求高。等待最终结果中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226694480, createdName=mariner2008, createdTime=Sat Jan 09 15:51:03 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883268, encodeId=204c88326848, content=9.7Awaiting AE Recommendation,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a133003278, createdName=502198970, createdTime=Mon Sep 07 09:49:45 CST 2020, time=2020-09-07, status=1, ipAttribution=)]
    2023-01-18 1e159c33m59(暂无匿称) 来自新疆

    审稿速度:1.0 | 投稿命中率:5.0
    偏重的研究方向:肿瘤;预后;生信
    经验分享:精心准备了1个月,审了不到一周直接给拒了……

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2125490, encodeId=26b621254901c, content=投稿以后一直Under Review,中间修改了一次格式,5天了这个状态也不知道送审没有?问助理编辑说已经送到编辑手里了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Wed Apr 12 19:24:43 CST 2023, time=2023-04-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1203553, encodeId=066812035532c, content=请问这个杂志还收几个CASE的这种文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/73A8DFA52E5E794376E9A901459F3815/100, createdBy=b0972241547, createdName=Mascara, createdTime=Thu Mar 17 19:44:04 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110666, encodeId=9f0f2110666e4, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;预后;生信<br>经验分享:精心准备了1个月,审了不到一周直接给拒了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74bd1969714, createdName=1e159c33m59(暂无匿称), createdTime=Wed Jan 18 00:13:30 CST 2023, time=2023-01-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1084305, encodeId=7075108430535, content=12-26投出一篇文章,编号870,按每年文章数200计算,接受率大概在四分之一,期待结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e05538742, createdName=李明胤1234, createdTime=Sun Dec 26 02:54:33 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091142, encodeId=23d1109114236, content=选刊时需要从高到低设置期刊梯度吗?一般设置几个梯度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091141, encodeId=ea4b109114125, content=如何评估自身文章的IF,或者说如何更好地定位自己的文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999047, encodeId=2a4599904e61, content=7月号投稿成功,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64245547622, createdName=ms7000000000217945, createdTime=Tue Jul 13 10:29:00 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969886, encodeId=942e9698867d, content=版面费好贵!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3cEsefDtr3SksqpiatQphbNU2zjlFgLM5KAxKCPSC5p6Zmf5dTnDwmicF8Q2meU3hoXs3t5B6KD8Q/132, createdBy=b5265362396, createdName=医学森4783, createdTime=Mon May 31 16:21:09 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914916, encodeId=40b191491635, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;病理;基因<br>经验分享:2020.12.26投稿---2020.12.30under review---2021.1.4awaiting AE assignment----2021.1.6Awaiting Referee assignment-----2021.1.7Awaiting Referee Scores----2021.1.9awaiting chief editor decision<br>祈祷中,杂志速度极快,以往经验3周肯定一审结束,语言要求高。等待最终结果中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226694480, createdName=mariner2008, createdTime=Sat Jan 09 15:51:03 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883268, encodeId=204c88326848, content=9.7Awaiting AE Recommendation,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a133003278, createdName=502198970, createdTime=Mon Sep 07 09:49:45 CST 2020, time=2020-09-07, status=1, ipAttribution=)]
    2021-12-26 李明胤1234

    12-26投出一篇文章,编号870,按每年文章数200计算,接受率大概在四分之一,期待结果

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2125490, encodeId=26b621254901c, content=投稿以后一直Under Review,中间修改了一次格式,5天了这个状态也不知道送审没有?问助理编辑说已经送到编辑手里了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Wed Apr 12 19:24:43 CST 2023, time=2023-04-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1203553, encodeId=066812035532c, content=请问这个杂志还收几个CASE的这种文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/73A8DFA52E5E794376E9A901459F3815/100, createdBy=b0972241547, createdName=Mascara, createdTime=Thu Mar 17 19:44:04 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110666, encodeId=9f0f2110666e4, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;预后;生信<br>经验分享:精心准备了1个月,审了不到一周直接给拒了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74bd1969714, createdName=1e159c33m59(暂无匿称), createdTime=Wed Jan 18 00:13:30 CST 2023, time=2023-01-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1084305, encodeId=7075108430535, content=12-26投出一篇文章,编号870,按每年文章数200计算,接受率大概在四分之一,期待结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e05538742, createdName=李明胤1234, createdTime=Sun Dec 26 02:54:33 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091142, encodeId=23d1109114236, content=选刊时需要从高到低设置期刊梯度吗?一般设置几个梯度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091141, encodeId=ea4b109114125, content=如何评估自身文章的IF,或者说如何更好地定位自己的文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999047, encodeId=2a4599904e61, content=7月号投稿成功,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64245547622, createdName=ms7000000000217945, createdTime=Tue Jul 13 10:29:00 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969886, encodeId=942e9698867d, content=版面费好贵!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3cEsefDtr3SksqpiatQphbNU2zjlFgLM5KAxKCPSC5p6Zmf5dTnDwmicF8Q2meU3hoXs3t5B6KD8Q/132, createdBy=b5265362396, createdName=医学森4783, createdTime=Mon May 31 16:21:09 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914916, encodeId=40b191491635, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;病理;基因<br>经验分享:2020.12.26投稿---2020.12.30under review---2021.1.4awaiting AE assignment----2021.1.6Awaiting Referee assignment-----2021.1.7Awaiting Referee Scores----2021.1.9awaiting chief editor decision<br>祈祷中,杂志速度极快,以往经验3周肯定一审结束,语言要求高。等待最终结果中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226694480, createdName=mariner2008, createdTime=Sat Jan 09 15:51:03 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883268, encodeId=204c88326848, content=9.7Awaiting AE Recommendation,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a133003278, createdName=502198970, createdTime=Mon Sep 07 09:49:45 CST 2020, time=2020-09-07, status=1, ipAttribution=)]
    2021-12-28 学医的彭于晏

    选刊时需要从高到低设置期刊梯度吗?一般设置几个梯度?

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2125490, encodeId=26b621254901c, content=投稿以后一直Under Review,中间修改了一次格式,5天了这个状态也不知道送审没有?问助理编辑说已经送到编辑手里了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Wed Apr 12 19:24:43 CST 2023, time=2023-04-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1203553, encodeId=066812035532c, content=请问这个杂志还收几个CASE的这种文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/73A8DFA52E5E794376E9A901459F3815/100, createdBy=b0972241547, createdName=Mascara, createdTime=Thu Mar 17 19:44:04 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110666, encodeId=9f0f2110666e4, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;预后;生信<br>经验分享:精心准备了1个月,审了不到一周直接给拒了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74bd1969714, createdName=1e159c33m59(暂无匿称), createdTime=Wed Jan 18 00:13:30 CST 2023, time=2023-01-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1084305, encodeId=7075108430535, content=12-26投出一篇文章,编号870,按每年文章数200计算,接受率大概在四分之一,期待结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e05538742, createdName=李明胤1234, createdTime=Sun Dec 26 02:54:33 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091142, encodeId=23d1109114236, content=选刊时需要从高到低设置期刊梯度吗?一般设置几个梯度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091141, encodeId=ea4b109114125, content=如何评估自身文章的IF,或者说如何更好地定位自己的文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999047, encodeId=2a4599904e61, content=7月号投稿成功,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64245547622, createdName=ms7000000000217945, createdTime=Tue Jul 13 10:29:00 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969886, encodeId=942e9698867d, content=版面费好贵!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3cEsefDtr3SksqpiatQphbNU2zjlFgLM5KAxKCPSC5p6Zmf5dTnDwmicF8Q2meU3hoXs3t5B6KD8Q/132, createdBy=b5265362396, createdName=医学森4783, createdTime=Mon May 31 16:21:09 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914916, encodeId=40b191491635, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;病理;基因<br>经验分享:2020.12.26投稿---2020.12.30under review---2021.1.4awaiting AE assignment----2021.1.6Awaiting Referee assignment-----2021.1.7Awaiting Referee Scores----2021.1.9awaiting chief editor decision<br>祈祷中,杂志速度极快,以往经验3周肯定一审结束,语言要求高。等待最终结果中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226694480, createdName=mariner2008, createdTime=Sat Jan 09 15:51:03 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883268, encodeId=204c88326848, content=9.7Awaiting AE Recommendation,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a133003278, createdName=502198970, createdTime=Mon Sep 07 09:49:45 CST 2020, time=2020-09-07, status=1, ipAttribution=)]
    2021-12-28 小动量

    如何评估自身文章的IF,或者说如何更好地定位自己的文章?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2125490, encodeId=26b621254901c, content=投稿以后一直Under Review,中间修改了一次格式,5天了这个状态也不知道送审没有?问助理编辑说已经送到编辑手里了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Wed Apr 12 19:24:43 CST 2023, time=2023-04-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1203553, encodeId=066812035532c, content=请问这个杂志还收几个CASE的这种文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/73A8DFA52E5E794376E9A901459F3815/100, createdBy=b0972241547, createdName=Mascara, createdTime=Thu Mar 17 19:44:04 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110666, encodeId=9f0f2110666e4, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;预后;生信<br>经验分享:精心准备了1个月,审了不到一周直接给拒了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74bd1969714, createdName=1e159c33m59(暂无匿称), createdTime=Wed Jan 18 00:13:30 CST 2023, time=2023-01-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1084305, encodeId=7075108430535, content=12-26投出一篇文章,编号870,按每年文章数200计算,接受率大概在四分之一,期待结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e05538742, createdName=李明胤1234, createdTime=Sun Dec 26 02:54:33 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091142, encodeId=23d1109114236, content=选刊时需要从高到低设置期刊梯度吗?一般设置几个梯度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091141, encodeId=ea4b109114125, content=如何评估自身文章的IF,或者说如何更好地定位自己的文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999047, encodeId=2a4599904e61, content=7月号投稿成功,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64245547622, createdName=ms7000000000217945, createdTime=Tue Jul 13 10:29:00 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969886, encodeId=942e9698867d, content=版面费好贵!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3cEsefDtr3SksqpiatQphbNU2zjlFgLM5KAxKCPSC5p6Zmf5dTnDwmicF8Q2meU3hoXs3t5B6KD8Q/132, createdBy=b5265362396, createdName=医学森4783, createdTime=Mon May 31 16:21:09 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914916, encodeId=40b191491635, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;病理;基因<br>经验分享:2020.12.26投稿---2020.12.30under review---2021.1.4awaiting AE assignment----2021.1.6Awaiting Referee assignment-----2021.1.7Awaiting Referee Scores----2021.1.9awaiting chief editor decision<br>祈祷中,杂志速度极快,以往经验3周肯定一审结束,语言要求高。等待最终结果中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226694480, createdName=mariner2008, createdTime=Sat Jan 09 15:51:03 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883268, encodeId=204c88326848, content=9.7Awaiting AE Recommendation,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a133003278, createdName=502198970, createdTime=Mon Sep 07 09:49:45 CST 2020, time=2020-09-07, status=1, ipAttribution=)]
    2021-07-13 ms7000000000217945

    7月号投稿成功,期待

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2125490, encodeId=26b621254901c, content=投稿以后一直Under Review,中间修改了一次格式,5天了这个状态也不知道送审没有?问助理编辑说已经送到编辑手里了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Wed Apr 12 19:24:43 CST 2023, time=2023-04-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1203553, encodeId=066812035532c, content=请问这个杂志还收几个CASE的这种文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/73A8DFA52E5E794376E9A901459F3815/100, createdBy=b0972241547, createdName=Mascara, createdTime=Thu Mar 17 19:44:04 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110666, encodeId=9f0f2110666e4, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;预后;生信<br>经验分享:精心准备了1个月,审了不到一周直接给拒了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74bd1969714, createdName=1e159c33m59(暂无匿称), createdTime=Wed Jan 18 00:13:30 CST 2023, time=2023-01-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1084305, encodeId=7075108430535, content=12-26投出一篇文章,编号870,按每年文章数200计算,接受率大概在四分之一,期待结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e05538742, createdName=李明胤1234, createdTime=Sun Dec 26 02:54:33 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091142, encodeId=23d1109114236, content=选刊时需要从高到低设置期刊梯度吗?一般设置几个梯度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091141, encodeId=ea4b109114125, content=如何评估自身文章的IF,或者说如何更好地定位自己的文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999047, encodeId=2a4599904e61, content=7月号投稿成功,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64245547622, createdName=ms7000000000217945, createdTime=Tue Jul 13 10:29:00 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969886, encodeId=942e9698867d, content=版面费好贵!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3cEsefDtr3SksqpiatQphbNU2zjlFgLM5KAxKCPSC5p6Zmf5dTnDwmicF8Q2meU3hoXs3t5B6KD8Q/132, createdBy=b5265362396, createdName=医学森4783, createdTime=Mon May 31 16:21:09 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914916, encodeId=40b191491635, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;病理;基因<br>经验分享:2020.12.26投稿---2020.12.30under review---2021.1.4awaiting AE assignment----2021.1.6Awaiting Referee assignment-----2021.1.7Awaiting Referee Scores----2021.1.9awaiting chief editor decision<br>祈祷中,杂志速度极快,以往经验3周肯定一审结束,语言要求高。等待最终结果中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226694480, createdName=mariner2008, createdTime=Sat Jan 09 15:51:03 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883268, encodeId=204c88326848, content=9.7Awaiting AE Recommendation,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a133003278, createdName=502198970, createdTime=Mon Sep 07 09:49:45 CST 2020, time=2020-09-07, status=1, ipAttribution=)]
    2021-05-31 医学森4783

    版面费好贵!

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2125490, encodeId=26b621254901c, content=投稿以后一直Under Review,中间修改了一次格式,5天了这个状态也不知道送审没有?问助理编辑说已经送到编辑手里了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Wed Apr 12 19:24:43 CST 2023, time=2023-04-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1203553, encodeId=066812035532c, content=请问这个杂志还收几个CASE的这种文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/73A8DFA52E5E794376E9A901459F3815/100, createdBy=b0972241547, createdName=Mascara, createdTime=Thu Mar 17 19:44:04 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110666, encodeId=9f0f2110666e4, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;预后;生信<br>经验分享:精心准备了1个月,审了不到一周直接给拒了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74bd1969714, createdName=1e159c33m59(暂无匿称), createdTime=Wed Jan 18 00:13:30 CST 2023, time=2023-01-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1084305, encodeId=7075108430535, content=12-26投出一篇文章,编号870,按每年文章数200计算,接受率大概在四分之一,期待结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e05538742, createdName=李明胤1234, createdTime=Sun Dec 26 02:54:33 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091142, encodeId=23d1109114236, content=选刊时需要从高到低设置期刊梯度吗?一般设置几个梯度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091141, encodeId=ea4b109114125, content=如何评估自身文章的IF,或者说如何更好地定位自己的文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999047, encodeId=2a4599904e61, content=7月号投稿成功,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64245547622, createdName=ms7000000000217945, createdTime=Tue Jul 13 10:29:00 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969886, encodeId=942e9698867d, content=版面费好贵!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3cEsefDtr3SksqpiatQphbNU2zjlFgLM5KAxKCPSC5p6Zmf5dTnDwmicF8Q2meU3hoXs3t5B6KD8Q/132, createdBy=b5265362396, createdName=医学森4783, createdTime=Mon May 31 16:21:09 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914916, encodeId=40b191491635, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;病理;基因<br>经验分享:2020.12.26投稿---2020.12.30under review---2021.1.4awaiting AE assignment----2021.1.6Awaiting Referee assignment-----2021.1.7Awaiting Referee Scores----2021.1.9awaiting chief editor decision<br>祈祷中,杂志速度极快,以往经验3周肯定一审结束,语言要求高。等待最终结果中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226694480, createdName=mariner2008, createdTime=Sat Jan 09 15:51:03 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883268, encodeId=204c88326848, content=9.7Awaiting AE Recommendation,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a133003278, createdName=502198970, createdTime=Mon Sep 07 09:49:45 CST 2020, time=2020-09-07, status=1, ipAttribution=)]
    2021-01-09 mariner2008

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:肿瘤;病理;基因
    经验分享:2020.12.26投稿---2020.12.30under review---2021.1.4awaiting AE assignment----2021.1.6Awaiting Referee assignment-----2021.1.7Awaiting Referee Scores----2021.1.9awaiting chief editor decision
    祈祷中,杂志速度极快,以往经验3周肯定一审结束,语言要求高。等待最终结果中。

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2125490, encodeId=26b621254901c, content=投稿以后一直Under Review,中间修改了一次格式,5天了这个状态也不知道送审没有?问助理编辑说已经送到编辑手里了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Wed Apr 12 19:24:43 CST 2023, time=2023-04-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1203553, encodeId=066812035532c, content=请问这个杂志还收几个CASE的这种文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/73A8DFA52E5E794376E9A901459F3815/100, createdBy=b0972241547, createdName=Mascara, createdTime=Thu Mar 17 19:44:04 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110666, encodeId=9f0f2110666e4, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;预后;生信<br>经验分享:精心准备了1个月,审了不到一周直接给拒了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74bd1969714, createdName=1e159c33m59(暂无匿称), createdTime=Wed Jan 18 00:13:30 CST 2023, time=2023-01-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1084305, encodeId=7075108430535, content=12-26投出一篇文章,编号870,按每年文章数200计算,接受率大概在四分之一,期待结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e05538742, createdName=李明胤1234, createdTime=Sun Dec 26 02:54:33 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091142, encodeId=23d1109114236, content=选刊时需要从高到低设置期刊梯度吗?一般设置几个梯度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091141, encodeId=ea4b109114125, content=如何评估自身文章的IF,或者说如何更好地定位自己的文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999047, encodeId=2a4599904e61, content=7月号投稿成功,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64245547622, createdName=ms7000000000217945, createdTime=Tue Jul 13 10:29:00 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969886, encodeId=942e9698867d, content=版面费好贵!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3cEsefDtr3SksqpiatQphbNU2zjlFgLM5KAxKCPSC5p6Zmf5dTnDwmicF8Q2meU3hoXs3t5B6KD8Q/132, createdBy=b5265362396, createdName=医学森4783, createdTime=Mon May 31 16:21:09 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914916, encodeId=40b191491635, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;病理;基因<br>经验分享:2020.12.26投稿---2020.12.30under review---2021.1.4awaiting AE assignment----2021.1.6Awaiting Referee assignment-----2021.1.7Awaiting Referee Scores----2021.1.9awaiting chief editor decision<br>祈祷中,杂志速度极快,以往经验3周肯定一审结束,语言要求高。等待最终结果中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226694480, createdName=mariner2008, createdTime=Sat Jan 09 15:51:03 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883268, encodeId=204c88326848, content=9.7Awaiting AE Recommendation,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a133003278, createdName=502198970, createdTime=Mon Sep 07 09:49:45 CST 2020, time=2020-09-07, status=1, ipAttribution=)]
    2020-09-07 502198970

    9.7Awaiting AE Recommendation,期待

    0

共45条页码: 1/5页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map